Frederic D. F.
- Country
- France
- Department
- Oncology
Research Overview
- Phase II Randomized Study of FOLFIRI Plus Zimberelimab and Domvanalimab Versus FOLFIRI in Patients With Second-Line Metastatic Gastro-Enteropancreatic or Unknown Origin Neuroendocrine Carcinoma
- Pumitamig and Combination Therapy Versus Bevacizumab and Combination Therapy in Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Adjuvant Phase III Randomized Trial of Capecitabine plus Temozolomide Versus Surveillance in R0‑resected Stage I‑III Pancreatic Neuroendocrine Tumors (ADJUPANET)
Data & Insights
Has run more than one trial at 300 of 534 partner sites.
Specializations
Gastrointestinal Oncology
Dedicated to investigating innovative treatments for colorectal cancer, with particular focus on circulating tumor DNA analysis and adjuvant therapies. Specializes in both stage II and III colon cancer management.
- Colon Cancer Treatment Optimization
- Molecular Biomarker Research
- Minimal Residual Disease Detection
Hepatobiliary Oncology
Explores advanced therapeutic approaches for hepatocellular carcinoma, including immunotherapy combinations and targeted treatments. Studies novel drug combinations incorporating atezolizumab and bevacizumab.
- Liver Cancer Immunotherapy
- First-line Systemic Treatments
- Combination Therapy Strategies
Upper GI Tract Oncology
Investigates treatment strategies for gastroesophageal adenocarcinoma and esophageal squamous cell carcinoma. Focuses on personalized approaches including chemotherapy de-escalation and targeted therapies.
- Gastric Cancer Management
- Treatment De-escalation Studies
- HER2-Positive Disease Therapy
Specialized Oncology Areas
Conducts research in rare gastrointestinal cancers including small bowel adenocarcinoma and neuroendocrine tumors. Develops treatment protocols for pancreatic adenocarcinoma.
- Rare GI Cancer Treatments
- Neuroendocrine Tumor Therapy
- Pancreatic Cancer Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.